The Indicator from Planet Money The Indicator from Planet Money

Why GLP-1s aren't lowering employers' costs

May 19, 2026 · 10m

Summary

Host Weyland Wong and reporter Julie Wernow examine whether employer coverage for GLP-1 weight loss drugs saves money. Through the story of Nick Miller, whose state job covers his Ozempic, they explore the health benefits versus financial costs. Health economist Chris Whaley explains that while these drugs improve health, they currently increase employer spending rather than reducing it, challenging the assumption that better health automatically lowers insurance claims.

Topics discussed

Intro and Indicator Newsletter announcement Nick's story: Ozempic, food noise, and employer coverage Sponsors: Mattress Firm, HomeServe, and NPR membership Nick's background and changing his view on medication Employer strategy: Gatekeeping and health benefits Economist Chris Whaley debunks cost-saving myths Savings come from restrictions, not health outcomes Conclusion, credits, and NPR promo segments

More from The Indicator from Planet Money

Tech blackouts, Black Friday fake-outs, and C-suite tariff cash-outs
Nov 20, 2026
Why the 'good old days' of American manufacturing are long gone
Nov 19, 2026
We got this economics podcast before GTA VI
Nov 18, 2026
How a tribal water deal could put a price tag on the Colorado River
Nov 17, 2026
Three influencer types and how they generate money
Nov 16, 2026
Listen ad-free on Castria